POLISCOPE
Back to feed
S133FEDERALUNKNOWN
High Impact

NAPA Reauthorization Act: Extending Alzheimer's Research and Coordination

Original title: NAPA Reauthorization Act

October 1, 2024

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The law ensures continued federal coordination of Alzheimer's research and public health strategies for the next decade, directly impacting how the government allocates resources and sets priorities for dementia care and prevention.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Alzheimer's patients and families

The law mandates the inclusion of a patient representative on the advisory council and expands research focus to include risk reduction and cognitive health.

Underserved populations

The law requires the project to specifically address disparities and include representatives from populations with higher lifetime risks for Alzheimer's.

Department of Justice, FEMA, and Social Security Administration

These agencies are now required to provide a designee to serve on the National Alzheimer's Project advisory council.

What changed

Last recorded activity October 1, 2024.

What's next

Introduced.

Summary

This law extends the National Alzheimer's Project Act through 2035 and expands the scope of federal research to include risk reduction, healthy aging, and outreach to . It also adds new federal agency representatives and patient advocates to the project's advisory council.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

How long does this extension last?
The project is extended through the year 2035.
Who is being added to the advisory council?
The council is expanding to include representatives from the Department of Justice, FEMA, the Social Security Administration, an individual with an Alzheimer's diagnosis, and a representative from a historically underserved population.
Does this law change the focus of Alzheimer's research?
Yes, it adds a focus on healthy aging, risk factor reduction, and promoting cognitive health, while also emphasizing the inclusion of and those with developmental disabilities.

Why It Matters

The law ensures continued federal coordination of Alzheimer's research and public health strategies for the next decade, directly impacting how the government allocates resources and sets priorities for dementia care and prevention.

News Coverage

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Expansion of Alzheimer's Scope

The law shifts the project's focus from purely clinical research to include preventative measures like 'healthy aging' and 'risk factor reduction'.

Connected Entities

other2 or more other designeesDesignees for the Alzheimer’s Project.Map →
organizationSocial Security AdministrationDesignee for the Alzheimer’s Project.Map →
organizationFederal Emergency Management AgencyDesignee for the Alzheimer’s Project.Map →
organizationDepartment of JusticeDesignee for the Alzheimer’s Project.Map →
organizationDepartment of Health and Human ServicesThe agency responsible for overseeing the National Alzheimer’s Project Act.Map →
bill_numberNational Alzheimer's Project ActThe core subject of the reauthorization.Map →
organizationU.S. Government Publishing OfficeSource of the document.Map →
otherDown syndromeSpecifically mentioned as an underserved population.Map →

Analysis Score

0–100
  • Significance85
    How much this matters to a regular citizen
  • Controversy5
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record